Simplify everything from site selection to study close-out
Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.
News
Better Matches, Faster: How Agentic AI Is Changing Clinical Trial Feasibility
By Sweta Pittala, VP, Technology Portfolio Management At a Glance Responding to Requests for Proposal (RFPs) is one of the most labor-intensive processes in clinical trial operations. Velocity’s Feasibility Agent … Read more
Kris Kowdley, MD Featured in Ipsen’s ELSPIRE Trial Announcement
Congratulations to Ipsen on positive Phase IIIb results from the ELSPIRE trial evaluating IQIRVO® (elafibranor) in patients with Primary Biliary Cholangitis (PBC). The trial met its primary endpoint with statistical … Read more
The New AI Baseline… and How Sponsors Build an Advantage
By Nick Spittal, Chief Operations Officer, Velocity Clinical Research How many times have you heard the term AI this week? Sponsors are investing in it, CROs are building for it, … Read more
What It Actually Means to Be a Partner in Clinical Research
By Andrew Reina, Chief Revenue Officer I spent the better part of two decades on the CRO side of clinical research, which gives you a particular vantage point. You see … Read more